Giorgio Minotti

Also affiliated with Fondazione Pisa, Campus Bio Medico University Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “Doxorubicin-Dexrazoxane from Day 1 for Soft-tissue Sarcomas: The Road to Cardioprotection”.

Doxorubicin-Dexrazoxane from Day 1 for Soft-tissue Sarcomas: The Road to Cardioprotection

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1376

N/A

0.457DataRank · unranked

20 citations

Giorgio Minotti, Robert S. Benjamin

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

European Heart Journal(2021)10.1093/eurheartj/ehab674

N/A

0DataRank · unranked

614 citations

Daniel J. Lenihan, Saro H. Armenian, Ana Barac, Anne Blaes, Daniela Cardinale +22 more

Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence

European Heart Journal(2024)10.1093/eurheartj/ehae105

N/A

0DataRank · unranked

36 citations

Ágnes Paál, Pietro Ameri, Wouter C. Meijers, Giorgio Minotti, Ioanna Andreadou +15 more